Next Steps After Receiving Symponi (Golimumab) Injection 11 Weeks Ago
You should receive your next Symponi injection now, as you are overdue for your scheduled dose based on the standard 4-week dosing interval for golimumab.
Understanding Symponi (Golimumab) Dosing Schedule
Symponi (golimumab) is a TNF-alpha inhibitor administered by subcutaneous injection. According to the FDA label, the standard dosing schedule for Symponi is:
- For most conditions: Once every 4 weeks 1
- The medication is designed to be administered on a regular schedule to maintain therapeutic levels in the body
Since it has been 11 weeks since your last injection, you are approximately 7 weeks overdue for your scheduled dose.
Immediate Next Steps
- Contact your healthcare provider immediately to schedule your next injection
- Do not administer a double dose to make up for the missed dose
- Prepare for potential disease flare due to the extended gap between doses
Considerations for Delayed Dosing
Potential Consequences of Delayed Dosing
- Decreased medication effectiveness
- Potential disease flare or symptom recurrence
- Possible development of antibodies against golimumab
Before Receiving Your Next Dose
Your healthcare provider should:
- Assess your current disease activity
- Evaluate for any signs of infection (golimumab can increase infection risk)
- Consider whether dose adjustment is needed after the extended gap
Administration Reminders
When receiving your next dose:
- Symponi should be stored in the refrigerator at 36°F to 46°F (2°C to 8°C) 1
- Allow the prefilled syringe to sit at room temperature for 30 minutes before injection 1
- Inspect the liquid - it should be clear to slightly yellow 1
- Choose an appropriate injection site (front of thighs or lower abdomen) 1
- Remain at the healthcare facility for at least 30 minutes after injection to monitor for any immediate reactions 2
Long-term Management
- Resume regular 4-week dosing schedule after this dose
- Consider setting reminders for future doses to prevent missed injections
- Report any new symptoms that may have developed during the extended gap
Special Considerations
Vaccination Timing
If you need any live vaccines, be aware that:
- Live attenuated vaccines should generally not be given while on TNF inhibitors like golimumab
- If absolutely necessary, live vaccines should be administered at least 4 weeks after your last golimumab dose 2
Monitoring for Side Effects
Watch for and report any:
- Signs of infection (fever, cough, flu-like symptoms)
- Injection site reactions
- New or worsening symptoms of your underlying condition
Remember that maintaining a consistent dosing schedule is crucial for achieving optimal therapeutic benefit from Symponi. Regular administration every 4 weeks helps maintain appropriate blood levels of the medication and provides the best chance for disease control.